Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached the press release in respect of results for the quarter and half year ended September 30, 202021-10-2020
21-10-2020
Syngene International Ltd - 539268 - Results-Financials For The Quarter And Half Year Ended September 30 ,2020
Please find attached financials for the quarter and half year ended September 30 ,202021-10-2020
Syngene International Ltd - 539268 - Outcome Of The Board Meeting
Please find attached the unaudited results for the quarter and half year ended September 30, 202021-10-2020
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find attached the Intimation of Conference Call for Analysts and Investors.16-10-2020
Syngene International Ltd - 539268 - Shareholding for the Period Ended September 30, 2020
Syngene International Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here13-10-2020
Syngene International Ltd - 539268 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Priyadarshini MahapatraDesignation :- Company Secretary and Compliance Officer12-10-2020
Syngene International Ltd - 539268 - Half Yearly Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015
Please find attached the Half Yearly Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 201507-10-2020
Syngene International Ltd - 539268 - Board Meeting Intimation for Intimation Of Board Meeting And Trading Window Closure
Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2020 ,inter alia, to consider and approve To consider and approve the un-audited Standalone and Consolidated financial results for the quarter and half year ended on September 30, 202007-10-2020
Syngene International Ltd - 539268 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find attached the Certificate under 74(5) of SEBI (DP) Regulations, 201805-10-2020
Syngene Intl joins global consortium of healthcare groups on Covid testing
The consortium, led by Bristol Myers Squibb, will focus on a wide range of aspects from research to clinical diagnostic applications, the company said in a statement02-10-2020